Trump has begun another trade war. Here's a timeline of how we got here
Canada's leader laments lost friendship with US in town that sheltered stranded Americans after 9/11
Chinese EV giant BYD's fourth-quarter profit leaps 73%
You're an American in another land? Prepare to talk about the why and how of Trump 2.0
Chalk talk: Star power, top teams and No. 5 seeds headline the women's March Madness Sweet 16
Purdue returns to Sweet 16 with 76-62 win over McNeese in March Madness
(Reuters) - Clario, a software provider for drugmakers, has confidentially filed for an initial public offering in the United States and is targeting a valuation of more than $10 billion, Bloomberg News reported on Tuesday.
The U.S. IPO market has witnessed an uptick in 2024 after a nearly two-year dry spell, as expectations of a soft landing for the economy encourage companies to list their shares.
The company is working with underwriters JPMorgan Chase & Co., Morgan Stanley, Jefferies Financial Group and UBS Group AG, the report added, citing people familiar with the development.
Clario did not immediately respond to a Reuters request for comment.
(Reporting by Pritam Biswas in Bengaluru; Editing by Pooja Desai)
